Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Conference Reports for NATAP Conference on Retroviruses and Opportunistic Infections Denver, Colorado March 3-6 2024 Back Tweet Semaglutide Trims Muscle Volume but Physical Function Not Lost CROI 2024 (Conference on Retroviruses and Opportunistic Infections), March 3-6, 2024, Denver Mark Mascolini Low-dose semaglutide, the GLP-1 receptor agonist that suppresses appetite and lowers weight, significantly decreased psoas muscle volume through 24 weeks in the SLIM LIVER trial of people with HIV infection and metabolic-associated steatotic liver disease (MASLD) [1]
Questions to Ask Before Starting a GLP-1 for Weight Loss If youre considering taking a semaglutide or any of the other GLP-1 medications for weight loss, treat the discussion with your doctor as you would for any other medication or health condition
However, some people may experience other, less common side effects
Similarly, Pieczykolan et al
